Table 1.

Correlation of TBX5 Expression and Clinicopathological Features of NSCLC Patients

Clinicopathological Features	No. of Cases	TBX5 Expression		p Value
		High	Low
Age(years)				0.566
≥55	61	25	36
<55	49	23	26
Gender				0.319
Female	38	14	24
Male	72	34	38
Histology				0.029*
Squamous cell carcinoma	20	14	6
Adenocarcinoma	37	15	22
Large cell carcinoma	53	19	34
Clinical stage				0.016*
I	33	21	12
II	16	7	9
III + IV	61	20	41
Lymph node status				0.035*
Metastasis	49	27	22
No metastasis	61	21	40
Pathological differentiation				0.932
Well	32	14	18
Moderately	58	26	32
Poorly	20	8	12

TBX5, T-box transcription factor 5; NSCLC, non-small cell lung carcinoma; TNM, tumor node metastasis.

^* p < 0.05.